<p>Canopy Growth Corp（多伦多证券交易所代码：WEED - 获取免费报告）的股价在周三交易中下跌了 0.6%。该股最低交易价格为 1.59 加元，最后交易价格为 1.60 加元。在交易中大约有 1,323,345 股成交，较日均成交量 2,306,358 股下降了 43%。该股此前收盘价为 1.61 加元。</p>
<p>获取 <strong>Canopy Growth</strong> 的提醒：</p>
<h2>分析师设定新的价格目标</h2>
<p>几家研究公司最近对 WEED 发表了看法。桑福德·C·伯恩斯坦在 1 月 14 日的研究报告中将 Canopy Growth 的目标价格从 5.30 加元下调至 2.50 加元。Benchmark 在 11 月 10 日的研究报告中将 Canopy Growth 的评级从 “卖出” 上调至 “持有”。最后，ATB Cormark Capital Markets 在 12 月 11 日的研究报告中将 Canopy Growth 的目标价格从 1.60 加元下调至 1.40 加元，并对该股给予 “表现不佳” 的评级。一位研究分析师对该股给予了 “持有” 评级，另一位则给予了 “卖出” 评级。根据 MarketBeat 的数据，该股的共识评级为 “减持”，共识目标价格为 1.95 加元。</p>
<p><strong>查看我们对 WEED 的最新分析</strong></p>
<h2>Canopy Growth 下跌 0.6%</h2>
<p>该公司的市值为 6.0458 亿加元，市盈率为-0.86，市盈增长比率为-0.01，贝塔值为 1.76。该公司的速动比率为 2.32，流动比率为 1.39，债务股本比率为 120.38。该业务的 50 日移动平均价格为 1.64 加元，200 日移动平均价格为 1.79 加元。</p>
<p>Canopy Growth（多伦多证券交易所代码：WEED - 获取免费报告）最近于 2 月 6 日发布了季度财报。该公司报告季度每股收益为 C($0.18)。Canopy Growth 的股本回报率为-108.18%，净利润率为-201.27%。该公司季度收入为 7454 万加元。作为一个整体，研究分析师预计 Canopy Growth Corp 在当前财政年度将发布-0.69 的每股收益。</p>
<h2>Canopy Growth 公司简介</h2>
<p>（获取免费报告）</p>
<p>Canopy Growth Corporation 及其子公司在加拿大从事医疗大麻的种植、持有和销售。其产品包括干花、油和浓缩物、软胶囊和大麻。该公司以 Tweed、Black Label、Spectrum Cannabis、DNA Genetics、Leafs By Snoop、CraftGrow 和 Foria 等品牌名称提供其产品。它还通过 Tweed Main Street 这一单一在线平台提供产品，使注册患者能够从不同生产商处购买各种品牌的医疗大麻。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票比 Canopy Growth 更好</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国 1776 年再次发生</li>
<li>这让我感到愤怒</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Canopy Growth 吗？</h2>
<p>在你考虑 Canopy Growth 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Canopy Growth 并不在名单上。</p>
<p>虽然 Canopy Growth 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Canopy Growth（多伦多证券交易所代码：WEED）股价下跌 0.6%，至 1.60 加元，交易量较平均水平下降 43%。分析师们设定了新的价格目标，Sanford C. Bernstein 将其目标从 5.30 加元下调至 2.50 加元，而 ATB Cormark 则将其目标从 1.60 加元下调至 1.40 加元。该股票的共识评级为 “减持”，价格目标为 1.95 加元。Canopy Growth 在上个季度报告了每股收益为负的 0.18 加元，预计本财年将发布每股收益为负的 0.69 加元。该公司专注于加拿大的医疗大麻产品</p>

<p>Canopy Growth Corp (TSE:WEED - Get Free Report)'s stock price was down 0.6% during trading on Wednesday . The stock traded as low as C$1.59 and last traded at C$1.60. Approximately 1,323,345 shares traded hands during trading, a decline of 43% from the average daily volume of 2,306,358 shares. The stock had previously closed at C$1.61.</p>
<div class="lb-trans"><p>Canopy Growth Corp（多伦多证券交易所代码：WEED - 获取免费报告）的股价在周三交易中下跌了 0.6%。该股最低交易价格为 1.59 加元，最后交易价格为 1.60 加元。在交易中大约有 1,323,345 股成交，较日均成交量 2,306,358 股下降了 43%。该股此前收盘价为 1.61 加元。</p>
</div><p>Get <strong>Canopy Growth</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Canopy Growth</strong> 的提醒：</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新的价格目标</h2>
</div><p>Several research firms have recently weighed in on WEED. Sanford C. Bernstein reduced their price objective on Canopy Growth from C$5.30 to C$2.50 in a research note on Wednesday, January 14th. Benchmark raised shares of Canopy Growth from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a research report on Monday, November 10th. Finally, ATB Cormark Capital Markets reduced their price target on shares of Canopy Growth from C$1.60 to C$1.40 and set an &#34;underperform&#34; rating on the stock in a research report on Thursday, December 11th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of &#34;Reduce&#34; and a consensus price target of C$1.95.</p>
<div class="lb-trans"><p>几家研究公司最近对 WEED 发表了看法。桑福德·C·伯恩斯坦在 1 月 14 日的研究报告中将 Canopy Growth 的目标价格从 5.30 加元下调至 2.50 加元。Benchmark 在 11 月 10 日的研究报告中将 Canopy Growth 的评级从 “卖出” 上调至 “持有”。最后，ATB Cormark Capital Markets 在 12 月 11 日的研究报告中将 Canopy Growth 的目标价格从 1.60 加元下调至 1.40 加元，并对该股给予 “表现不佳” 的评级。一位研究分析师对该股给予了 “持有” 评级，另一位则给予了 “卖出” 评级。根据 MarketBeat 的数据，该股的共识评级为 “减持”，共识目标价格为 1.95 加元。</p>
</div><p><strong>View Our Latest Analysis on WEED</strong></p>
<div class="lb-trans"><p><strong>查看我们对 WEED 的最新分析</strong></p>
</div><h2>Canopy Growth Trading Down 0.6%</h2>
<div class="lb-trans"><h2>Canopy Growth 下跌 0.6%</h2>
</div><p>The firm has a market cap of C$604.58 million, a price-to-earnings ratio of -0.86, a price-to-earnings-growth ratio of -0.01 and a beta of 1.76. The company has a quick ratio of 2.32, a current ratio of 1.39 and a debt-to-equity ratio of 120.38. The business has a 50 day moving average price of C$1.64 and a 200-day moving average price of C$1.79.</p>
<div class="lb-trans"><p>该公司的市值为 6.0458 亿加元，市盈率为-0.86，市盈增长比率为-0.01，贝塔值为 1.76。该公司的速动比率为 2.32，流动比率为 1.39，债务股本比率为 120.38。该业务的 50 日移动平均价格为 1.64 加元，200 日移动平均价格为 1.79 加元。</p>
</div><p>Canopy Growth (TSE:WEED - Get Free Report) last released its quarterly earnings results on Friday, February 6th. The company reported C($0.18) EPS for the quarter. Canopy Growth had a negative return on equity of 108.18% and a negative net margin of 201.27%.The company had revenue of C$74.54 million for the quarter. As a group, research analysts expect that Canopy Growth Corp will post -0.69 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Canopy Growth（多伦多证券交易所代码：WEED - 获取免费报告）最近于 2 月 6 日发布了季度财报。该公司报告季度每股收益为 C($0.18)。Canopy Growth 的股本回报率为-108.18%，净利润率为-201.27%。该公司季度收入为 7454 万加元。作为一个整体，研究分析师预计 Canopy Growth Corp 在当前财政年度将发布-0.69 的每股收益。</p>
</div><h2>Canopy Growth Company Profile</h2>
<div class="lb-trans"><h2>Canopy Growth 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.</p>
<div class="lb-trans"><p>Canopy Growth Corporation 及其子公司在加拿大从事医疗大麻的种植、持有和销售。其产品包括干花、油和浓缩物、软胶囊和大麻。该公司以 Tweed、Black Label、Spectrum Cannabis、DNA Genetics、Leafs By Snoop、CraftGrow 和 Foria 等品牌名称提供其产品。它还通过 Tweed Main Street 这一单一在线平台提供产品，使注册患者能够从不同生产商处购买各种品牌的医疗大麻。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Canopy Growth</li>
<li>The gold chart Wall Street is terrified of…</li>
<li>America’s 1776 happening again</li>
<li>This makes me furious</li>
<li>Buy this Gold Stock Before May 2026</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 Canopy Growth 更好</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国 1776 年再次发生</li>
<li>这让我感到愤怒</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Canopy Growth Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Canopy Growth 吗？</h2>
</div><p>Before you consider Canopy Growth, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Canopy Growth 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Canopy Growth 并不在名单上。</p>
</div><p>While Canopy Growth currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Canopy Growth 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Canopy Growth (TSE:WEED) 的股价下跌了 0.6% - 现在是卖出的时候吗？